Exclusive Live coverage: Curious2018 – Future Insight: Day OneCurious2018 – Future Insight is a new flagship healthcare conference launched this year by Merck to bring some Share XExclusive Live coverage: Curious2018 – Future Insight: Day Onehttps://pharmaphorum.com/views-and-analysis/exclusive-live-coverage-curious2018-future-insight-day-one/
Raising the bar in liver cancer therapypharmaphorum interviews professor Jeff Evans, from the University of Glasgow’s Institute of Cancer Sciences, about findings of a Share XRaising the bar in liver cancer therapyhttps://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/
Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s successGary Hendler, chairman and CEO of EMEA region for Eisai, talked to Richard Staines at pharmaphorum about findings Share XEisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s successhttps://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/
ASCO 2018 – Tuesday 5th June: Tesaro developing checkpoint comboBreast cancer has been one area where checkpoint inhibitors have not yet gained traction – but that might Share XASCO 2018 – Tuesday 5th June: Tesaro developing checkpoint combohttps://pharmaphorum.com/views-and-analysis/asco-2018-tesaro-checkpoint-combo/
ASCO 2018 – Monday 4th June: BMS tries different tack as Merck & Co locks out lung cancer I/OMerck & Co has dominated proceedings at the American Society of Clinical Oncology (ASCO), with a steady flow Share XASCO 2018 – Monday 4th June: BMS tries different tack as Merck & Co locks out lung cancer I/Ohttps://pharmaphorum.com/event-coverage/asco-2018-bms-merck-co-locks-out-lung-cancer-i-o/
ASCO 2018 – Sunday 3rd June: Opdivo/Nektar, AbbVie’s new leukaemia combo, and moreBristol-Myers Squibb is hoping to revive its Opdivo cancer immunotherapy by combining it with an experimental agent from Share XASCO 2018 – Sunday 3rd June: Opdivo/Nektar, AbbVie’s new leukaemia combo, and morehttps://pharmaphorum.com/views-analysis-oncology/asco_2018-opdivo-nektar-abbvies-leukaemia/
ASCO 2018 – Friday 1st and Saturday 2nd June: Bluebird Bio’s CAR-T shines, plus blood tests for lung cancerThe American Society of Clinical Oncology (ASCO) has already singled out CAR-T therapies as the most promising advance Share XASCO 2018 – Friday 1st and Saturday 2nd June: Bluebird Bio’s CAR-T shines, plus blood tests for lung cancerhttps://pharmaphorum.com/views-analysis-oncology/asco-round-up-bluebird-bios-car-t-plus-lynch-syndrome-screening/
The pharmaphorum ASCO 2018 daily bulletinpharmaphorum is on-site at ASCO 2018 and will be delivering daily insight into all of the main conference Share XASCOhttps://pharmaphorum.com/asco/
ASCO 2018 Preview – what to expect from this year’s conferencepharmaphorum will be presenting live online coverage of this year’s ASCO 2018 conference, the biggest event of the Share XASCO 2018 Preview – what to expect from this year’s conferencehttps://pharmaphorum.com/views-and-analysis/asco-2018-preview-conference/
Exclusive: Day three coverage of eyeforpharma Barcelona 2018pharmaphorum in conjunction with IQVIA present exclusive highlights and coverage generated on-site at the 2018 eyeforpharma Barcelona conference. Share XExclusive: Day three coverage of eyeforpharma Barcelona 2018https://pharmaphorum.com/sales-marketing/exclusive-day-three-live-coverage-from-2018-eyeforpharma-barcelona/
Exclusive: Day two live coverage from 2018 eyeforpharma Barcelonapharmaphorum in conjunction with IQVIA present exclusive highlights and coverage generated on-site at the 2018 eyeforpharma Barcelona conference. Share XExclusive: Day two live coverage from 2018 eyeforpharma Barcelonahttps://pharmaphorum.com/event-coverage/exclusive-day-two-live-coverage-2018-eyeforpharma-barcelona/
Exclusive insights and coverage from eyeforpharma Barcelona 2018Exclusive live coverage from eyeforpharma Barcelona 2018, brought to you by pharmaphorum and IQVIA pharmaphorum in conjunction with Share XExclusive insights and coverage from eyeforpharma Barcelona 2018https://pharmaphorum.com/event-coverage/exclusive-day-one-live-coverage-2018-eyeforpharma-barcelona-2/
